BriMindInvest Logo

NTLA (NTLA) Stock Analysis

BriMind AI Score

Proprietary
25
Weak
Price CAGR
-5.1%
1Y Return
+70.3%
Analyst Upside
+70.0%
Rev Growth
-9.5%

Score based on historical price CAGR, revenue growth, analyst upside, and valuation factors. Updated daily.

Compare NTLA with Peers

NTLA vs CRSPIntellia Therapeutics vs CRISPR Therapeutics — In-Vivo

Unlock the Full NTLA Analysis

Interactive price charts, real-time AI signals, advanced DCF models, portfolio tracking, earnings analysis, and side-by-side peer comparisons. Start your 21-day free trial — no credit card required.

Start Free TrialBrowse All Stocks
← Back to Home · Browse All Stock Analysis